Belgium plans temporary ban on use of Ozempic for weight loss

Belgium wants to temporarily ban the use of Novo Nordisk's diabetes drug Ozempic as a weight loss treatment amid a shortage of the medicine, the Belgian health minister said on Monday.

"We have told doctors that they must reserve this drug for their patients who have type 2 diabetes but we see that this strategy does not work," Belgian federal health minister Franck Vandenbroucke told Belgian broadcaster RTBF.